Literature DB >> 12834262

Divergence in signaling pathways involved in promotion of cell viability mediated by bFGF, NGF, and EGF in PC12 cells.

Takakazu Kawamata1, Tomoko Yamaguchi, Kazuo Shin-ya, Tomokatsu Hori.   

Abstract

We employed a series of inhibitors of intracellular cascade to disclose the precise molecular mechanisms by which basic fibroblast growth factor (bFGF) promotes viability of PC12 cells and compared with nerve growth factor (NGF) and epidermal growth factor (EGF). The MEK 1 and 2 inhibitors, U0126 and PD98059, significantly suppressed cell viability mediated by bFGF in a dose-dependent manner, and to a greater extent compared with EGF and NGF. The degree of MEK dependency for growth factor-mediated cell viability was estimated to be in the order of bFGF, EGF, and NGF. Rapamycin strongly inhibited the effect of NGF on cell viability, compared with bFGF and EGF. The mechanisms of action of NGF-mediated cell viability may depend largely on p70 S6 kinase-related signal transduction pathways comparing to bFGF and EGF. The present findings suggest that different signal transduction systems may be involved in the molecular mechanisms by which bFGF, NGF, and EGF mediate cell viability.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12834262     DOI: 10.1023/a:1024284529945

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  31 in total

1.  Rap1 mediates sustained MAP kinase activation induced by nerve growth factor.

Authors:  R D York; H Yao; T Dillon; C L Ellig; S P Eckert; E W McCleskey; P J Stork
Journal:  Nature       Date:  1998-04-09       Impact factor: 49.962

2.  A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway.

Authors:  H Kouhara; Y R Hadari; T Spivak-Kroizman; J Schilling; D Bar-Sagi; I Lax; J Schlessinger
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

3.  Intracisternal basic fibroblast growth factor (bFGF) enhances behavioral recovery following focal cerebral infarction in the rat.

Authors:  T Kawamata; N E Alexis; W D Dietrich; S P Finklestein
Journal:  J Cereb Blood Flow Metab       Date:  1996-07       Impact factor: 6.200

4.  FKBP-rapamycin inhibits a cyclin-dependent kinase activity and a cyclin D1-Cdk association in early G1 of an osteosarcoma cell line.

Authors:  M W Albers; R T Williams; E J Brown; A Tanaka; F L Hall; S L Schreiber
Journal:  J Biol Chem       Date:  1993-10-25       Impact factor: 5.157

5.  Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor.

Authors:  R Yao; G M Cooper
Journal:  Science       Date:  1995-03-31       Impact factor: 47.728

6.  p38 mitogen-activated protein kinase activation is required for fibroblast growth factor-2-stimulated cell proliferation but not differentiation.

Authors:  P Maher
Journal:  J Biol Chem       Date:  1999-06-18       Impact factor: 5.157

7.  Posttreatment with intravenous basic fibroblast growth factor reduces histopathological damage following fluid-percussion brain injury in rats.

Authors:  W D Dietrich; O Alonso; R Busto; S P Finklestein
Journal:  J Neurotrauma       Date:  1996-06       Impact factor: 5.269

8.  Pretreatment with intraventricular basic fibroblast growth factor decreases infarct size following focal cerebral ischemia in rats.

Authors:  N Koketsu; D J Berlove; M A Moskowitz; N W Kowall; C G Caday; S P Finklestein
Journal:  Ann Neurol       Date:  1994-04       Impact factor: 10.422

9.  Phosphatidylinositol 3-kinase is activated by nerve growth factor and epidermal growth factor in PC12 cells.

Authors:  A N Carter; C P Downes
Journal:  J Biol Chem       Date:  1992-07-25       Impact factor: 5.157

Review 10.  Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation.

Authors:  C J Marshall
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

View more
  1 in total

1.  Lignosus rhinocerotis (Cooke) Ryvarden mimics the neuritogenic activity of nerve growth factor via MEK/ERK1/2 signaling pathway in PC-12 cells.

Authors:  Syntyche Ling-Sing Seow; Lee-Fang Eik; Murali Naidu; Pamela David; Kah-Hui Wong; Vikineswary Sabaratnam
Journal:  Sci Rep       Date:  2015-11-06       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.